BioMark Diagnostics Inc. filed its Annual on Jul 11, 2022 for the period ending Mar 31, 2022. In this report its auditor, PricewaterhouseCoopers LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.173 EUR | -4.42% | -1.14% | +17.69% |
1st Jan change | Capi. | |
---|---|---|
+17.69% | 17.63M | |
-19.88% | 10.81B | |
+52.46% | 3.36B | |
-32.75% | 2.22B | |
-14.15% | 2.16B | |
-27.44% | 1.55B | |
+21.60% | 1.04B | |
-3.28% | 746M | |
-31.50% | 425M | |
-43.16% | 405M |
- Stock Market
- Equities
- 20B Stock
- News Biomark Diagnostics Inc.
- BioMark Diagnostics Inc. Auditor Raises 'Going Concern' Doubt